Relay Therapeutics's total assets for Q3 2025 were $670.00M, a decrease of -8.07% from the previous quarter. RLAY total liabilities were $62.29M for the fiscal quarter, a -1.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.